Cheng Su

Biomarin Pharmaceutical
Executive Director, Data Sciences and Analytics
Cheng got his Ph.D. in statistics from NCSU and has 22 years of experiences in both nonclinical and clinical areas. Cheng has a broad interpest in applying statistical thinking and analytics to support drug research and development. His specific areas of expertise include high throughput screening, drug combination, predictive modeling, genomics and genetics, biomarker, algorithm development, automated analysis system and adaptive designs. For over three years, Cheng led the effort within Amgen, his former employer, to develop a Centralized Statistical Monitoring solution that has been successfully applied across company portfolio. Cheng is currently the Executive Director of Data Sciences & Analytics at BioMarin.

My Speakers Sessions

Monday, June 24